Biotech: Page 37
-
Technology at the Speed of Light
The impact that the Internet and follow-on technologies have had on all areas of the life-sciences is well-documented throughout this special section, and the majority of our thought leaders have identified this as the biggest game changer in the last 10 years. Going even further, these same thou...
By PharmaVoice Team • March 7, 2011 -
Talent Pool
Pharmaceutical POOL Dr. Robert CUDDIHY Sanofi-Aventis Adds to Diabetes Team Sanofi-Aventis U.S. has appointed Robert Cuddihy, M.D., VP, medical diabetes head in the U.S. Dr. Cuddihy is responsible for developing and executing the U.S. medical affairs strategy for Sanofi-Aventis’s diabetes divisio...
By PharmaVoice Team • March 3, 2011 -
Explore the Trendline➔
Stock via Getty ImagesTrendlineOncology
As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.
By PharmaVoice staff -
What's New
Through its recent acquisition of MedPage Today, a news organization serving healthcare professionals, Everyday Health has added a significant offering for healthcare professionals to its portfolio of consumer health information brands. MedPage provides healthcare professionals with peer-reviewed...
By PharmaVoice Team • March 3, 2011 -
Digital Marketing: Dare to be Different
Research shows creativity is one of the most important components of a successful campaign, however, our experts say there are several other elements behind a campaign that need to be present to make the best of what digital media have to offer. Among them are matching the audience with the most ...
By PharmaVoice Team • Jan. 26, 2011 -
Talent Pool
Pharmaceutical POOL Robert DAVIS Dr. Ludwig HANTSON Baxter International Forms Medical Products Business Baxter International has appointed Robert Davis corporate VP and president of its newly created medical products business, which combines the company’s renal and medication delivery businesses...
By PharmaVoice Team • Jan. 26, 2011 -
UpFront
Awards… Cephalon wins PRSA Awards CRF Health Wins at Clio Natrel Wins Rx Club Award INDUSTRY at Large Smarty Apps… E-Promotion on the E-Rise Supporting Science Education Lucky 14 Pharma Saves Green by Going Green Disruptive Technology, Disruptive times Top Innovators Podcasts Best Practices for Y...
By PharmaVoice Team • Jan. 26, 2011 -
Emerging Market: Ola Brazil
With every passing year, the pharmaceutical industry becomes more global in its outlook and reach. In recognition of our shrinking world, PharmaVOICE is taking you on a journey across the globe. Our first stop is Latin America’s largest market, Brazil. Brazil is familiar territory to the pharma...
By Kim Ribbink • Dec. 27, 2010 -
Biotech: Raising Capital in a Tight Market
The global financial crisis has made it challenging for the biotechnology industry to raise capital to fund innovation. Experts say venture capital money is still available, but often the VC community is looking for lower-risk, short-term projects. As a result, biotech companies are increasingly ...
By Denise Myshko • Dec. 27, 2010 -
Achieving Global Launch Excellence
The details of what comprise a global launch vary depending upon who is doing the defining, but experts can agree that the launch environment is becoming more challenging. And with the value of the global pharmaceutical market expected to grow 5% to 7% in 2011, according to IMS Health, the incent...
By PharmaVoice Team • Dec. 27, 2010 -
The Genome: The Next 10 Years
In just one generation medicine will take a huge leap forward. That is, if researchers are right about how data from the human genome can be used to address disease. There has been a great deal of optimism about how sequencing the human genome might create new diagnostics and new medicines. Ten y...
By Denise Myshko • Dec. 27, 2010 -
Last Word
Pharma Forecast Simon King, a pharmaceutical company analyst at Datamonitor, comments on trends expected to impact “big pharma" in 2011. PV: Despite a challenging year for Roche, you say restructuring will help the company maintain a strong fiscal position. What other factors do you think will h...
By PharmaVoice Team • Dec. 27, 2010 -
Talent Pool
Pharmaceutical POOL Dr. Milind DESHPANDE Achillion Pharmaceuticals Promotes R&D President Achillion Pharmaceuticals, which is focused on the discovery and development of small-molecule drugs to combat challenging infectious diseases, has promoted Chief Scientific Officer Milind Deshpande, Ph....
By PharmaVoice Team • Dec. 27, 2010 -
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: New Solutions Help Harness Social Monitoring Insights CRM Update In Other Technology News… AstraZeneca BioClinica Chiltern International Cmed Technology Decision Resources PharmaVigilant E-Upgrades and Enhancement...
By PharmaVoice Team • Dec. 27, 2010 -
What's New
Trends: Changing market forces and the trend toward more flexible business models have inspired the creation of dynamic companies better positioned to explore opportunities overlooked by larger life-sciences organizations. NEW AMERICAN THERAPEUTICS, a specialty pharmaceutical company co-founded ...
By PharmaVoice Team • Dec. 27, 2010 -
UpFront
Awards… Abbott Diversity Leader John F. Crowley Honored Rx club Awards Dr. Paul Janssen Award Industry at Large Merck & The Street Executive Moves — Changes at the Top Podcasts White papers » Abbott Diversity Leader Abbott has been named one of the top 10 companies for diversity in a new surv...
By PharmaVoice Team • Dec. 27, 2010 -
A Globally Focused Industry
There will be an overall shift in the pharmaceutical industry from a very Western-centric model to a global one. Disease areas that were once considered niche are now given priority and the more prevalent disease therapeutic areas in the mature markets have taken a backseat. Vaccines, biologics, ...
By Denise Myshko • Nov. 10, 2010 -
A More Conservative Regulatory Landscape
In the last few years, the FDA has come under strong criticism for the rate of adverse events, high-profile drug recalls, and contamination of both food and drug products. Agency officials have made steps to address drug safety and provide a more open and transparent regulatory environment. For t...
By PharmaVoice Team • Nov. 10, 2010 -
The Crystal Ball
Dr. John Arrowsmith Scientific Director Thomson Reuters, which delivers critical information to leading decision makers in the financial, legal, tax and accounting, healthcare, science, and media markets. For more information, visit lifesciencesconsulting.thomsonreuters.com. 1. Outsourcing. There...
By PharmaVoice Team • Nov. 10, 2010 -
Talent Pool
Biopharmaceutical POOL Michael BAILEY Dr. Donna RADZIK Aveo Pharmaceuticals Bolsters Leadership Aveo Pharmaceuticals, a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics, has appointed Michael Bailey chief commercial officer. Mr. Bailey joins Av...
By PharmaVoice Team • Nov. 9, 2010 -
Women in Science: A Work in Progress
It’s a fact that gender discrepancy in the field of science exists. It’s a fact that changes in legislation, academic policies, and an overall increased awareness of gender bias are improving a woman’s chances of succeeding in all the STEM (science, technology, engineering, and math) fields. Howe...
By PharmaVoice Team • Sept. 29, 2010 -
Tomorrow's MSL: Specialist or Generalist?
MSLs have been around for 40 years, and with the evolution of technology, increased regulations and government scrutiny, and the squeeze of the declining salesforce, today the role may be even more crucial to the drug-development and commercialization process. According to Robin Winter-Sperry, M....
By PharmaVoice Team • Sept. 29, 2010 -
Pharma is Taking Its Byte of the Apple
Sales reps have been using mobile CRM applications on their smart phones and laptops for years, but the larger screen and “wow" factor of the iPad may bring additional benefits and functions to bear. Novelty of iPad Increases Mobile Technology Demand With the recent emergence of more s...
By PharmaVoice Team • Sept. 29, 2010 -
Last Word
Current Challenges in BioScience What are some of the hot button issues in biotechnology today? Molineaux. For small companies, it is all about funding and the difficulties associated with raising capital. There is a great deal of risk aversion in the capital community today, which is making thin...
By PharmaVoice Team • Sept. 28, 2010 -
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: CenterWatch Service Matches Sponsors, Investigative Sites PPD, Microsoft Collaborate to Improve REMS Management Cegedim Dendrite Streamlines Tracking, Reporting Capabilities QPharma Assists with Marketing Spend ...
By PharmaVoice Team • Sept. 28, 2010 -
UpFront
Awards Sanofi-Aventis Receives HBA’s ACE Award The Healthcare Businesswomen’s Association (HBA) has named Sanofi-Aventis US as the winner of the 2010 HBA ACE Award. The Sanofi-Aventis US program, WISE (Women Inspiring Sanofi-Aventis Excellence), is an internal women’s network with more than 1,000...
By PharmaVoice Team • Sept. 28, 2010